Advanced search×

Parvovirus B19 transmission by a high-purity factor VIII concentrate.

Transfusion 45(6):1003-10 (2005) PMID 15935000

Parvovirus B19 (B19) is known to cause a variety of human diseases in susceptible individuals by close contact via the respiratory route or by transfusion of contaminated blood or blood products. In this study, whether a case of B19 transmission was causally related to the infusion of implicated lots of a solvent/detergent (S/D)-treated, immunoaffinity-purified factor VIII concentrate (antihemophilic factor [human][AHF]) was investigated.

DOI: 10.1111/j.1537-2995.2005.04387.x
Version: za2963e q8zae q8zb8 q8zc4 q8zdc q8ze0 q8zf4 q8zgd

Similar articles you may find interesting…

  1. Reasons for poor adherence to antiretroviral therapy postnatally in HIV-1 infected women treated for their own health: experiences from the ...

    BMC Public Health 13(1):450 (2013) PMID 23647555

    Most women in the study did not acknowledge poor adherence until confronted with the viral load figures. Then, however, they revealed multiple reasons for failing to adhere. They said that their motivation to take ART decreased once they had protected their children from becoming infected and succes...
  2. Dielectric Breakdown in Silica-Amorphous Polymer Nanocomposite Films: The Role of the Polymer Matrix.

    ACS Appl Mater Interfaces (2013) PMID 23639183

    We compare the dielectric properties for four high-purity amorphous polymer films (polymethyl methacrylate, polystyrene, polyimide, and poly-4-vinylpyridine) incorporating uniformly dispersed silica colloids (up to 45% v/v). Factors known to contribute to premature breakdown-field exclusion and aggl...
  3. Prevalence of the molecular marker of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in Benin seven years af...

    Malar J 12(1):147 (2013) PMID 23634705

    These results suggest a persistence level of resistance of P. falciparum to CQ and SP, seven years after the recommendation of the change of malaria treatment policy in Benin. The distribution of mutations studied was neither related to age nor to clinical status....